FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135350581> ?p ?o ?g. }

• W3135350581 endingPage "205" @default.
• W3135350581 startingPage "198" @default.
• W3135350581 abstract "Inflammatory Bowel Disease (IBD) treatment may increase the risk of infections. Vaccines are part of the comprehensive IBD patient care. The aim of this study was to describe indications and adherence of immunizations in IBD and identify possible associated factors. A cross-sectional, analytic study was conducted in patients from an IBD Program of a tertiary center in Chile, between April – June 2019. Patients were asked to answer a vaccine survey and information also was obtained from the National Immunization Registry. Descriptive and association statistic were used (χ2; p < 0.05). A total of 243 patients were included (148 ulcerative colitis (UC), 86 Crohn´s disease (CD) and 9 non-classifiable IBD). Only six patients (2%) of IBD patients received a complete immunization schedule. The highest vaccine rates were against influenza (67%), hepatitis B virus (40%), 13-valent pneumococcal (34%) and 23-polysaccharide pneumococcal (16%). The influenza vaccine rate has significantly increased, reaching 67% in 2019. The survey showed that 23% of patients have not been immunized with any vaccine, mainly due to lack of time, lack of medical prescription and high cost. In this cohort, although vaccination rates are higher than previously reported, adherence to IBD immunization program would be improved, being considered since diagnosis by the multidisciplinary team. El tratamiento de la Enfermedad Inflamatoria Intestinal (EII) puede aumentar el riesgo de infección. La inmunización es parte del manejo integral de la atención de estos pacientes. El objetivo de este estudio es describir la prescripción y adherencia a la vacunación en pacientes con EII e identificar los posibles factores asociados a ésta. Estudio analítico, descriptivo, transversal en pacientes de un Programa de EII de Chile, entre abril-junio 2019. A los pacientes se les solicitó responder un cuestionario acerca de la adherencia a la vacunación. La información de las vacunas se obtuvo del Registro Nacional de Inmunizaciones. Se realizó análisis estadístico descriptivo y de asociación (χ2; p < 0.05). Se incluyeron 243 pacientes con EII (148 Colitis Ulcerosa (CU), 86 enfermedad de Crohn (EC) y 9 EII no-clasificable). Sólo 6 pacientes (2%) recibieron el esquema de inmunización completo. Las vacunas con los mayores porcentajes fueron contra la influenza (67%), virus hepatitis B (40%), neumocócica 13-valente (34%) y neumocócica 23-polisacárida (16%), siendo las dos primeras más frecuentes en EC vs CU (p: <0.05). La administración de la vacuna contra la influenza ha aumentado significativamente, alcanzando un 67% el 2019. La encuesta mostró que el 23% no ha sido inmunizado con ninguna vacuna, principalmente por falta de tiempo, falta de prescripción médica y el alto costo económico. En esta cohorte, aunque las tasas de vacunación son más altas que las reportadas previamente, la adherencia al programa de inmunización debe mejorar. siendo consideradas desde el diagnóstico por el equipo multidisciplinario." @default.
• W3135350581 created "2021-03-15" @default.
• W3135350581 creator A5001716503 @default.
• W3135350581 creator A5012720460 @default.
• W3135350581 creator A5051133217 @default.
• W3135350581 creator A5054259114 @default.
• W3135350581 creator A5062867380 @default.
• W3135350581 creator A5067352612 @default.
• W3135350581 creator A5070722323 @default.
• W3135350581 creator A5074094092 @default.
• W3135350581 creator A5085375386 @default.
• W3135350581 date "2021-03-01" @default.
• W3135350581 modified "2023-09-24" @default.
• W3135350581 title "Are patients with inflammatory bowel disease receiving adequate immunisation?" @default.
• W3135350581 cites W1572221909 @default.
• W3135350581 cites W1992118657 @default.
• W3135350581 cites W1992574837 @default.
• W3135350581 cites W2032478850 @default.
• W3135350581 cites W2039802948 @default.
• W3135350581 cites W2053235033 @default.
• W3135350581 cites W2065971915 @default.
• W3135350581 cites W2080286486 @default.
• W3135350581 cites W2092097194 @default.
• W3135350581 cites W2117905220 @default.
• W3135350581 cites W2145593067 @default.
• W3135350581 cites W2233914371 @default.
• W3135350581 cites W2469950461 @default.
• W3135350581 cites W2530287906 @default.
• W3135350581 cites W2597956983 @default.
• W3135350581 cites W2781636401 @default.
• W3135350581 cites W2797152839 @default.
• W3135350581 cites W2947972508 @default.
• W3135350581 cites W2954934400 @default.
• W3135350581 cites W2964277243 @default.
• W3135350581 cites W2969345308 @default.
• W3135350581 cites W2976362764 @default.
• W3135350581 cites W2992173421 @default.
• W3135350581 cites W3004265818 @default.
• W3135350581 cites W3005337935 @default.
• W3135350581 cites W3005544777 @default.
• W3135350581 cites W4293777482 @default.
• W3135350581 doi "https://doi.org/10.1016/j.gastre.2020.06.018" @default.
• W3135350581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33131901" @default.
• W3135350581 hasPublicationYear "2021" @default.
• W3135350581 type Work @default.
• W3135350581 sameAs 3135350581 @default.
• W3135350581 citedByCount "1" @default.
• W3135350581 countsByYear W31353505812021 @default.
• W3135350581 crossrefType "journal-article" @default.
• W3135350581 hasAuthorship W3135350581A5001716503 @default.
• W3135350581 hasAuthorship W3135350581A5012720460 @default.
• W3135350581 hasAuthorship W3135350581A5051133217 @default.
• W3135350581 hasAuthorship W3135350581A5054259114 @default.
• W3135350581 hasAuthorship W3135350581A5062867380 @default.
• W3135350581 hasAuthorship W3135350581A5067352612 @default.
• W3135350581 hasAuthorship W3135350581A5070722323 @default.
• W3135350581 hasAuthorship W3135350581A5074094092 @default.
• W3135350581 hasAuthorship W3135350581A5085375386 @default.
• W3135350581 hasConcept C126322002 @default.
• W3135350581 hasConcept C159654299 @default.
• W3135350581 hasConcept C187212893 @default.
• W3135350581 hasConcept C203014093 @default.
• W3135350581 hasConcept C22070199 @default.
• W3135350581 hasConcept C2778260677 @default.
• W3135350581 hasConcept C2778866548 @default.
• W3135350581 hasConcept C2779134260 @default.
• W3135350581 hasConcept C2779301066 @default.
• W3135350581 hasConcept C2779664119 @default.
• W3135350581 hasConcept C2780479503 @default.
• W3135350581 hasConcept C2780801004 @default.
• W3135350581 hasConcept C2781253189 @default.
• W3135350581 hasConcept C3020803494 @default.
• W3135350581 hasConcept C523546767 @default.
• W3135350581 hasConcept C54355233 @default.
• W3135350581 hasConcept C71924100 @default.
• W3135350581 hasConcept C86803240 @default.
• W3135350581 hasConceptScore W3135350581C126322002 @default.
• W3135350581 hasConceptScore W3135350581C159654299 @default.
• W3135350581 hasConceptScore W3135350581C187212893 @default.
• W3135350581 hasConceptScore W3135350581C203014093 @default.
• W3135350581 hasConceptScore W3135350581C22070199 @default.
• W3135350581 hasConceptScore W3135350581C2778260677 @default.
• W3135350581 hasConceptScore W3135350581C2778866548 @default.
• W3135350581 hasConceptScore W3135350581C2779134260 @default.
• W3135350581 hasConceptScore W3135350581C2779301066 @default.
• W3135350581 hasConceptScore W3135350581C2779664119 @default.
• W3135350581 hasConceptScore W3135350581C2780479503 @default.
• W3135350581 hasConceptScore W3135350581C2780801004 @default.
• W3135350581 hasConceptScore W3135350581C2781253189 @default.
• W3135350581 hasConceptScore W3135350581C3020803494 @default.
• W3135350581 hasConceptScore W3135350581C523546767 @default.
• W3135350581 hasConceptScore W3135350581C54355233 @default.
• W3135350581 hasConceptScore W3135350581C71924100 @default.
• W3135350581 hasConceptScore W3135350581C86803240 @default.
• W3135350581 hasIssue "3" @default.
• W3135350581 hasLocation W31353505811 @default.
• W3135350581 hasOpenAccess W3135350581 @default.
• W3135350581 hasPrimaryLocation W31353505811 @default.

• next